Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis
A method of treating and/or preventing atopic dermatitis is described. The method includes use of a compound of the avermectin family, possibly ivermectin, or a compound of the milbemycin family in a pharmaceutically acceptable carrier.
1. A method for treating atopic dermatitis, the method comprising: topically applying to the skin of a human subject in need thereof a pharmaceutical composition comprising 0.003% ivermectin by weight, relative to the total weight of the composition.
2. The method as defined by claim 1 , wherein the human subject in need thereof is a pregnant woman, a child, or an infant.
3. The method as defined by claim 1 , wherein the pharmaceutical composition is in the form of an emulsion, a cream, a lotion, a gel, or a solution.
4. The method as defined by claim 2 , wherein the human subject in need thereof is a pregnant woman.
5. The method as defined by claim 2 , wherein the human subject in need thereof is a child.
6. The method as defined by claim 2 , wherein the human subject in need thereof is an infant.
7. The method as defined by claim 3 , wherein the pharmaceutical composition is in the form of an emulsion.
8. The method as defined by claim 3 , wherein the pharmaceutical composition is in the form of a cream.
9. The method as defined by claim 3 , wherein the pharmaceutical composition is in the form of a lotion.
10. The method as defined by claim 3 , wherein the pharmaceutical composition is in the form of a gel.
11. The method as defined by claim 3 , wherein the pharmaceutical composition is in the form of a solution.